The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of postoperative complications on survival outcomes in patients with cT3/4a gastric cancer.
 
Masanori Tokunaga
No Relationships to Disclose
 
Yukinori Kurokawa
Honoraria - Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Medtronic; MSD; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Yakult Honsha
 
Yuichiro Doki
Speakers' Bureau - Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Abbott Japan; Ajinomoto; Astellas Pharma; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kaken Pharmaceutical; Lilly; MSD; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda; Tsumura & Co.; Yakult Honsha
 
Ryunosuke Machida
No Relationships to Disclose
 
Shuji Takiguchi
No Relationships to Disclose
 
Yuya Sato
No Relationships to Disclose
 
Hitoshi Katai
Honoraria - Covidien/Medtronic; Kyowa Hakko Kirin; Taiho Pharmaceutical
 
Norimasa Fukushima
No Relationships to Disclose
 
Yasunori Nishida
No Relationships to Disclose
 
Haruhiko Cho
No Relationships to Disclose
 
Takanobu Yamada
No Relationships to Disclose
 
Masahide Kaji
No Relationships to Disclose
 
Junya Fujita
No Relationships to Disclose
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Ajinomoto; Chugai Pharma; Daiichi Sankyo; Johnson & Johnson; Lilly; Medtronic; Miyarisan pharmaceutical; Miyarisan pharmaceutical; MSD; Nihonkayaku; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO; TERUMO
Consulting or Advisory Role - Chugai Pharma; MSD Oncology; Novartis
Research Funding - Chugai Pharma; Lilly; Lilly; Lilly; Novartis; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Masanori Terashima
Honoraria - Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)